Last price paid | 0.23 | |
Change | -11.54% [ -0.03 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 14.05.2024 17:20 |
Fixing | n.a. |
Settlement date | 15.05.2023 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +12.50% |
Year to date (YTD) | -43.90% |
1 month | -23.33% |
3 months | -39.47% |
1 year | n.a. |
3 years | n.a. |
Issue price | 0.20 |
Underlying price on issue | 46.20 |
Premium | 0.03% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1250732984 |
Symbol | IBSNMZ |
Security | 125073298 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Basilea Pharmaceu N, CH0011432447 |
Underlying ISIN | CH0011432447 |
Funding level | 54.144300 |
Stop-loss level | 52.032000 |
Distance to stop-loss level | 17.72% |
Long/Short type | Short |
Subscription ratio | 50.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 11.05.2023 |
Premium | 2.95% |
Premium p.a. | n.a. |
Leverage | 3.93 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 9.944300 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
Compagnie Financi... | 144.90 |
Swiss Re | 109.85 |
LOGITECH INT. | 82.70 |
NOVARTIS N | 93.68 |
ROCHE GS | 236.80 |
Name | Price |
---|---|
Partners Group Ho... | 1'258.00 |
ABB Ltd | 47.05 |
Alcon AG | 79.90 |
GEBERIT N | 561.00 |
KUEHNE & NAGEL | 249.50 |